You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Litigation Details for Ravgen, Inc. v. Progenity, Inc. (D. Del. 2020)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Ravgen, Inc. v. Progenity, Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Try a Trial .
Biologic Drugs cited in Ravgen, Inc. v. Progenity, Inc.

The biologic drugs covered by the patents cited in this case are ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , and ⤷  Try a Trial .

Details for Ravgen, Inc. v. Progenity, Inc. (D. Del. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-12-20 1 Complaint United States Patent Nos. 7,727,720 (the “’720 Patent”) and 7,332,277 (the “’277 Patent”) (collectively…number of patents and patent applications that are related to subject matter similar to the Patents-in-Suit…collectively the “Patents-in-Suit”), arising under the Patent Laws of the United States, 35 U.S.C. §§ 271 et …resulted in the issuance of several patents, including the Patents-in-Suit. Case 1:20-cv-01734-RGA-JLH…United States Patent and Trademark Office on February 19, 2008. The inventor of the patent is Ravinder External link to document
2021-03-23 10 Counterclaim AND Answer to Complaint United States Patent Nos. 7,727,720 (the “’720 Patent”) and 7,332,277 (the “’277 Patent”) (collectively…United States Patent Nos. 7,727,720 (the “’720 Patent”) and 7,332,277 (the “’277 Patent”) (collectively… Declaration of Invalidity of U.S. Patent No. 7,727,720 6. Progenity realleges and incorporates… Declaration of Non-Infringement of U.S. Patent No. 7,727,720 14. Progenity realleges and incorporates…a claim for alleged patent infringement of the Patents-in-Suit under the Patent Laws of the United External link to document
2021-04-13 14 Answer to Counterclaim Declaration of Invalidity of U.S. Patent No. 7,727,720 6. Ravgen incorporates by … Declaration of Non-Infringement of U.S. Patent No. 7,727,720 14. Ravgen incorporates by …it is the legal owner by assignment of the ’720 patent. 9. Ravgen admits that it has alleged…indirectly infringe one or more claims of the ’720 patent. 10. Ravgen admits that Progenity …infringing any valid and enforceable claim of the ’720 Patent. The remaining allegations in Paragraph 10 External link to document
2020-12-20 3 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,727,720 B2 ;US 7,332,277 …HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 US 7,727,720 B2 …Trademarks or ✔ Patents. G ( G the patent action involves… Progenity, Inc. PATENT OR DATE OF PATENT …G Other Pleading PATENT OR DATE OF PATENT External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.